SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Approves GE Healthcare’s SenoBright Spectral Mammography Device

October 17, 2011 | 
1 min read
The U.S. Food and Drug Administration has cleared GE Healthcare’s SenoBright contrast enhanced spectral mammography unit.
FDA Approvals Europe
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Pictured: Roche tower in Basel, Switzerland
Manufacturing
Roche Seeks Antibiotic Partner as Rising Manufacturing Costs Drive Supply Rethink
February 24, 2026
 · 
1 min read
 · 
Nick Paul Taylor
screenshot of Marty Makary speaking on the Megyn Kelly Show
Vaccines
FDA’s Makary Backs mRNA Vaccines but Says Companies ‘Can Fund Their Own Research’
February 24, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of man walking in the beach between two blue seas, surreal abstract path concept
Rare disease
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases
February 23, 2026
 · 
3 min read
 · 
Nick Paul Taylor
Conceptual origami paper plane pulling business finance growth chart line flying upwards on blue sky background.
Approvals
Vanda Rebounds From Jet Lag Rejection With FDA Nod for Bipolar, Schizophrenia Drug
February 23, 2026
 · 
2 min read
 · 
Tristan Manalac